Rita Sobral

Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.

Cooley advised Kpler, a fast-growing data and analytics firm on a mission to build one platform for global trade intelligence, on its acquisition of Spire Global’s maritime business for approximately $241 million.

Cooley advised Clinical Microbiomics, a leading innovator in bioinformatics and systems biology for the microbiome field based in Copenhagen, on its merger with CosmosID, a leading CLIA-certified, GxP-compliant microbiome contract research organization based in Maryland. 

Read more

Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) conditions, on its acquisition by Ironwood, with an estimated aggregate consideration of approximately $1 billion.